Xanthine oxidase-IN-9
Product Specifications
UNSPSC Description
Xanthine oxidase-IN-9 (Icarisids E) (Compound 2) is a potent xanthine oxidase (XOD) inhibitor with an IC50 of 31.81 μM[1].
Target Antigen
Xanthine Oxidase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/xanthine-oxidase-in-9.html
Solubility
10 mM in DMSO
Smiles
CC(C)(O)CCC1=C2C(C(C(O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O)O[C@H]4[C@@H]([C@@H]([C@H](CO4)O)O)O)=C(C5=CC=C(C=C5)OC)O2)=O)=C(C=C1O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O)CO)O
Molecular Weight
826.79
References & Citations
[1]Ye ZJ, et al. New prenylflavonol glycosides with xanthine oxidase inhibitory activity from the leaves of Cyclocarya paliurus. Bioorg Chem. 2020 Aug;101:104018.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N10433/Xanthine-oxidase-IN-9-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N10433/
Clinical Information
No Development Reported
CAS Number
2571069-61-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6297588-01 0.1 mL
FABP7, CT (FABP7, BLBP, FABPB, MRG, Fatty acid-binding protein, brain, Brain lipid-binding protein, Brain-type fatty acid-binding protein, Fatty acid-binding protein 7, Mammary-derived growth inhibitor related) (MaxLight 550)
Ask
View Details